AI assistant
IRIDEX CORP — Director's Dealing 2014
Mar 6, 2014
34978_dirs_2014-03-06_51d046a2-41bc-4c36-a712-7a1b4cd7d371.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IRIDEX CORP (IRIX)
CIK: 0001006045
Period of Report: 2014-03-04
Reporting Person: GARRETTSON GARRETT A (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-03-04 | Common Stock | M | 11250 | $6.39 | Acquired | 41049 | Direct |
| 2014-03-04 | Common Stock | S | 4993 | $9.2238 | Disposed | 36056 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-03-04 | Stock Option Right to Buy | $6.39 | M | 11250 | Disposed | 2014-09-22 | Common Stock (11250) | Direct |
Footnotes
F1: The sale price reported in Column 4 of Table 1 represents the weighted average sale price of the shares sold, ranging from $9.13 to $9.28 per share. Upon request by the Commission staff, the Issuer, or a security holder of Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
F2: This option was granted pursuant to IRIDEX Corporation's incentive Director Option Plan and is exempt pursuant to Rule 16b-3.
F3: Shares subject to the option are fully vested and immediately exercisable.